Table 4.

Influence of main clinical medication on lncRNAs expression in RA patients.

Group	Number	GAS5	linc0597	H19
Prednisone (mg/day)
≤7.5	36	0.61 (0.37, 0.94)	0.61 (0.46, 0.81)	0.58 (0.30, 0.87)
>7.5	37	0.42 (0.34, 0.68)	0.62 (0.48, 0.78)	0.55 (0.31, 0.82)
DMARDS
Yes	44	0.51 (0.36, 0.81)	0.62 (0.47, 0.78)	0.61 (0.34, 0.84)
No	29	0.53 (0.34, 0.69)	0.59 (0.47, 0.80)	0.43 (0.29, 0.84)
Botanical preparation
Yes	22	0.51 (0.36, 0.84)	0.63 (0.46, 0.82)	0.59 (0.46, 1.13)
No	51	0.53 (0.34, 0.76)	0.62 (0.48, 0.79)	0.49 (0.27, 0.80)

DMARDS, disease modifying antirheumatic drugs.